Explore tweets tagged as #seagen
Genomics expert Kevin McKernan: "This may be the largest carcinogenic hit EVER to the human population". "They know something". "[Pfizer] put $43 billion into the acquisition of Seagen [so] they're buying up the cancer companies".
71
2K
3K
$SGEN Seagen filed its 10-K for 2022 on 2/15 and mentioned the below related to takeover provisions: . “ Anti-takeover provisions could make it more difficult for a third party to acquire us ” . But not even before a month after 10-K filing, they got acquired by Pfizer on
2
2
14
@sciqst Question: Had $NWBO given the following presentation in June 2022 instead of June 2023, would Pfizer still have acquired Seagen?.
0
0
10
#AVCT. This is what $1.8Bn looked like last year:. Profound Bio was a ADC startup led by Seagen veterans, founded in 2018. It had two rounds of funding. Series A - $70m; Series B - $112M (February 2024) . ProfoundBio was taken over two months after their series B funding in
0
3
41
@grok @vendedoruruguay @SenseReceptor @RobertKennedyJr @US_FDA @pfizer @Jikkyleaks @Kevin_McKernan Kevin McKernan exposes Pfizer's bait-and-switch:.They used a clean batch for trials… then injected the world with process 2 — loaded with SV40 promoter sequences. They hid #SV40 from the @US_FDA. Then @pfizer bought Seagen, a cancer treatment company, for $43 billion. > “This
1
1
2
#NWBO I know, I know is Chat GPT, but still:.In my opinion if NWBO is apporved for all solid tumors, with Autologous manufacturing scaling, US + EU + China + Japan + Latam. with reimbursement, the valuation shoul be much more than Seagen.
5
0
45
$vktx, $pfe:.Bourla bought Seagen for $43b a couple years ago and that acquisition is expected to generate up to $10b/yr by 2030. (2024 was $3.1b). $vktx has potential for the same numbers by 2030 for almost 1/3 the price. Make a tender offer!! Force a vote. many stuck at $85/sh.
4
2
20
In other news,.Pfizer acquired SeaGen and Trillium.
Week 11 2025 Cancer Mortality Update. 🚨Cancer mortality is officially exhibiting a non-linear rise trajectory. I was waiting to make this observation, first out of conservancy, but also from a hope that it would not even manifest. However, cancer is now accelerating mildly.
14
108
310
Seagen’s Regulatory Pathway for Tukysa: A Detailed Walkthrough and $NWBO Potential Parallel Strategy. Executive Summary:.This comprehensive analysis explores Seagen Inc.’s successful regulatory strategy for Tukysa through Project Orbis and the Access Consortium. It then outlines.
1
1
43
CRIMINAL: First, Pfizer made billions off deadly COVID “vaccines.”. Now, they’re set to cash in on "turbo cancers.". Pfizer’s head of cancer, expects their new cancer drugs from Seagen could bring in $10 billion a year by 2030. Why is Pfizer so focused on cancer? Maybe because
6
42
92
Merck terminated the collaboration with Seagen after spending $1.6b and signed a deal with Daiichi by paying $5.5 bln, and potentially up to $22 bln for its three ADCs as claimed in the PR. Do Daiichi's ADCs outperform Seagen's to such an extent that Merck was willing to switch
Merck spent $1.3b on the acquisition of Imago for its LSD1 inhibitor. See how LSD1 inhibitor can affect DC function. It seems like Merck has been collecting all the components complementary to DCVax products. Lysine-specific demethylase 1 (LSD1) inhibitors can modulate
1
0
12
Merck, Daiichi pull approval application for ADC in lung cancer. Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape'. Merck Missed on Seagen, But Comes Back With Potential $22B Daiichi ADC.
0
0
8
Covaids vaccinations increase your risk of turbo cancers, specifically the Pfizer mRNA, possibly due to the hidden SV40 sequences that were not included in the version used for FDA trials, but deployed to everyone else. Oh, and Pfizer is buying up cancer companies, like Seagen
0
0
0
☎️ Genomics-expert Kevin McKernan:. ☎️ Dit kan de grootste kankerverwekkende ramp OOIT zijn voor de mensheid. “Ze weten iets.”. “[Pfizer] heeft 43 miljard dollar geïnvesteerd in de overname van Seagen, dus ze kopen kankerbedrijven op.”. **Ontdek de schokkende waarheid achter deze
1
4
4
$ABCL update: Baker Bros now owns ~9.3% of AbCellera, steadily adding to their position. Known for big biotech wins (like an $8B payout from Seagen), the Baker Bros are patient, science-driven investors. Their quiet accumulation signals long-term conviction.
11
14
175
$MRk felt $40 B was too much for Seagen with 4 approved cancer drugs, including breakthroughs (EV) and a full ADC platform. And now they are paying.$10 B for nebulizer ( although good ) .$PFE may not have overpaid overall.
5
0
28
Pfizer acquired Seagen in 2023 for $43 billion, and shut down construction on a $350 million manufacturing facility the following year.
0
0
0